Searchable abstracts of presentations at key conferences in endocrinology

ea0084ps1-01-07 | COVID & Thyroid Disease | ETA2022

The course and outcome of subacute thyroiditis: A retrospective analysis and predictive model

de Filette Jeroen , de rop jonas , barbe kurt , bravenboer bert

Background: Subacute thyroiditis (SAT) is a destructive thyroiditis which is presumably caused by a viral infections or post-viral inflammatory response. Thyroid dysfunction evolves through a set of stages (hyperthyroidism - hypothyroidism - euthyroidism) and is usually temporary, although some patients may develop permanent hypothyroidism. The risk factors for permanent hypothyroidism remain unclear.Methods: A retrospective analysis of patients with SAT...

ea0088022 | Abstracts | BES2022

Rapid growing thyroid nodule: the good one in the bad clothes

Marchi Lucrezia De , Filette Jeroen de , Johan Verhelst

Background: Primary thyroid lymphoma (PTL) is a rare thyroid tumor that accounts for only 5% of thyroid malignancies, but is associated with higher mortality than differentiated thyroid cancer. The major risk factor for thyroid lymphoma is the presence of Hashimoto’s thyroiditis (HT) with an estimated 60-fold increased risk. The lymphocytic infiltrate in HT appears to develop into lymphoma in a minority of patients. The differential diagnosis between Hashimoto’s thyr...

ea0057012 | Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review of the literature | BES2018

Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review of the literature

de Filette Jeroen MK , Joeri Pen , Brigitte Velkeniers , Kharagjitsingh Aan V

Introduction: Immune checkpoint inhibitors have revolutionized the treatment of advanced malignancies. These monoclonal antibodies target cytotoxic T-lymphocyte antigen-4 (CTLA-4), programmed cell death 1 (PD-1) or its ligand (PD-L1). Endocrine side effects are common, and while hypophysitis and thyroid disorders are predominant, checkpoint-blockade associated diabetes mellitus deserves further notice.Methods: We present the case of a 61-year old male wi...

ea0056gp211 | Pituitary Clinical | ECE2018

A systematic review and meta-analysis of endocrine-related adverse events associated with immune checkpoint inhibitors

de Filette Jeroen , Andreescu Corina , Cools Filip , Bravenboer Bert , Velkeniers Brigitte

Background: Monoclonal antibodies targeting CTLA-4 and PD-1/PD-L1 are promising for a wide range of advanced malignacies. These immune checkpoint inhibitors (ICI) provoke endocrine adverse events including hypopituitarism and primary thyroid disease.Methods: PubMed was searched through August 22nd, 2017, for relevant articles on endocrinopathies and ICI, by two reviewers independently (J.d.F. and C.A.). The weighted incidence and odds-ratio were estimate...

ea0064027 | Catastrophic antiphospholipid syndrome with bilateral adrenal hemorrhage: a case report | BES2019

Catastrophic antiphospholipid syndrome with bilateral adrenal hemorrhage: a case report

Lucrezia De Marchi , Jeroen M K de Filette , Bastiaan Sol , Corina E Andreescu , Rastislav Kunda , Peter Buydens , Brigitte Velkeniers

Background: Adrenal insufficiency is a rare but potentially life threatening complication of the antiphospholipid antibody syndrome (APS). The adrenal gland is the most commonly involved endocrine organ with adrenal insufficiency reported in 0.4% of APS cases. Adrenal failure more often follows other thromboembolic manifestations of APS.Case report: We report a 25-year-old male with systemic lupus erythematosus (SLE) with antiphospholipid syndrome (tripl...

ea0064038 | Pheochromocytoma-induced Takotsubo syndrome: when you hear hoofbeats, it may be a zebra! | BES2019

Pheochromocytoma-induced Takotsubo syndrome: when you hear hoofbeats, it may be a zebra!

Jerrold Spapen , Jeroen de Filette , Bastiaan Sol , Aan Kharagjitsing , Brigitte Velkeniers , Bert Bravenboer , Stijn Lochy , Corina Andreescu

Pheochromocytoma is a rare catecholamine-secreting tumor with variable clinical manifestations. A possible cardiac presentation is acute left ventricular wall motion abnormality in the heart also known as the Takotsubo syndrome. Takotsubo stress cardiomyopathy was first described in 1990 in Japan and current knowledge remains limited. We report a case of pheochromocytoma-induced Takotsubo syndrome. A 43-year-old woman acutely developed nausea, severe chest pain, and dyspnoea d...

ea0079019 | Abstracts | BES2021

COVID-19 & Cushing’s disease in a patient with ACTH-secreting pituitary carcinoma

Jeroen M.K. de Filette , Bastiaan Sol , Gil Awada , Corina E. Andreescu , David Unuane , Duc Nam Nguyen , Sandrine Aspeslagh , Jan Poelaert , Brigitte Velkeniers , Bert Bravenboer

Background : The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is of an unprecedented scale, with an ever-growing impact on healthcare systems. The clinical presentation of coronavirus disease 2019 (COVID-19) is diverse, ranging from asymptomatic illness to respiratory failure requiring admission to the intensive care unit (ICU). Risk factors for severe presentation include old age, male gender, underlying comorbidities such as metabolic syndr...

ea0079020 | Abstracts | BES2021

HLA-DR4/DR13 in a patient with durvalumab-induced thyroiditis

Filette de , M.K Jeroen , Rop Jonas De , Stephanie Andre , Lynn De Mey , Sandrine Aspeslagh , Rafik Karmali , der Auwera Bart J Van , Bert Bravenboer

Background: Immune checkpoint inhibitors (ICI) targeting cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), programmed cell death protein 1 and its ligand (PD-1/PD-L1) are the current standard-of-care for many advanced cancers (1). This novel therapeutic approach comes with its costs in the form of immune-related adverse events (irAE). The underlying mechanisms are not yet fully understood. We explore the role of HLA in endocrinopathy related to ICI therapy using an interes...